HIV quantification: Clinical applications

Lancet

Volumn 347, Issue 8994, 1996, Pages 71-73

  Volberding, P A ^a  

^a SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; SHORT SURVEY; VIRUS TITRATION;

EID: 0030029348     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)90205-6     Document Type: Article

References (16)

1. P. Bagnarelli S. Menzo A. Manzin M. Giacca Pe Varaldo M. Clementi Detection of human immunodeficiency virus type 1 genomic RNA in plasma samples by reverse-transcription polymerase chain reaction J Virol Methods 34 1991 89 95
2. C. Pachl Ja Todd Dg Kern Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay J AIDS 8 1995 446 454
3. Y. Cao Dd Ho J. Todd Clinical evaluation of branched DNA signal amplification for quantifying HIV type 1 in human plasma AIDS Res Hum Retrovir 11 1995 353 361
4. H. Revets, D. Marissens, S. Dewit, N. Clumeck, S. Lauwers, G. Zissis, Comparison of three HIV-1, RNA quantification assays: NASBA HIV-1 RNA QT, amplicor HIV monitor and quantiplex HIV RNA assay (Proceedings of the Molecular Approaches to Laboratory Diagnosis, San Francisco, California Feb 18-21, 1995).
5. Hj Lin Le Myers B. Yen-Leiberman Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA J Infect Dis 170 1994 553 562
6. C. Verhofstede S. Reniers F. Van Wanzeele J. Plum Evaluation of proviral copy number and plasma RNA level as early indicators of progression in HIV-1 infection: correlation with virological and immunological markers of disease AIDS 8 1994 1421 1427
7. C. Loveday A. Hill Prediction of progression to AIDS with serum HIV-1 RNA and CD4 count Lancet 345 1995 790 791
8. W. Paxton, R. Coombs, J. McElrath, et al., Longitudinal analysis of quantitative virologic measures in HIV-1 infected individuals with >400 CD4+ cells/µL (Program and Abstracts of the 2nd National Conference on Human Retroviruses and Related Infections. Jan 29-Feb 2, 1995 (abstr 232)).
9. Jw Mellors La Kingsley Cr Rinaldo Jr Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion Ann Intern Med 122 1995 537 579
10. S. Yerly L. Kaiser B. Mermillod C. Baumberger B. Hirschel L. Perrin Response of HIV RNA to didanosine as a predictive marker of survival AIDS 9 1995 159 163
11. 3 (Program and Abstracts of the Second National Conference on Human Retroviruses and Related Infections, Washington, DC, Feb 1, 1995 (abstr LB34)).
12. M. Holodniy Da Katzenstein Dm Israelski Tc Merigan Reduction in plasma human immunodeficiency virus ribonucleic acid after dideoxynucleoside therapy as determined by the polymerase chain reaction J Clin Invest 88 1991 1755 1759
13. 2 microglubin surrogate markers (Proceedings of the Tenth International Conference on AIDS, International Conference on STD, Aug 7-12, 1995, Yokohama, Japan (abstr 254B)).
14. S. Jurriaans Gj Weverling J. Goudsmit Distinct changes in HIV type 1 RNA versus p24 antigen levels in serum during short-term zidovudine therapy in asymptomatic individuals with and without progression to AIDS AIDS Res Hum Retroviruses 11 1995 473 479
15. D. Havlir Sh Cheeseman M. McLaughlin High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection J Infect Dis 171 1995 537 545
16. 3 J Infect Dis 172 1995 1379 1383